← All reviews

Case 28 · Graduation Day

WikiGen

The paradox at the center — the most valuable biological data is the data least likely to move — is a fundable problem, and the custody-plus-TEE mechanism is complete on paper; but the pitch buries both under tangled syntax, a seven-item feature dump, zero traction, zero market math, and a closing ask that is a slogan, not a number.

Wiki5:56 pitchreviewed 2026-08-17
4

01 Scorecard · 12 dimensions

Problem8"The most valuable biological data in the world is also the data least likely to move… When data does not move, science also can't" — a real paradox, well named, and "It belongs to someone's life" makes it felt.
Why now5Cheaper whole-genome sequencing and TEEs are both mentioned but never assembled into a "this is only possible now" argument — ingredients on the counter, sentence never cooked.
Insight / secret6"You bring the data to the model" plus "The system releases only the output that was agreed in advance" is a clean inversion — it just arrives at minute three, after the room has been lost twice.
Solution clarity6The mechanism is complete: funded capped evaluation, owner keeps custody, TEE runs it, only the pre-agreed output releases. But it is spoken through self-corrections and drowned by the feature dump that follows.
Product / demo3No demo. The one product line — "The view is filtered only by the address recovered from your signed arena session" — is UI documentation read aloud with no context.
Moat2Never addressed, and "The verifier f- can be swappable" suggests the core component is commoditized. Nothing answers why another confidential-compute marketplace can't do this.
Market3Both marketplace sides are named (sponsors vs. biobanks/hospitals) but there is zero sizing, zero pricing, zero math.
Business model2"Funds a capped evaluation" implies a take rate — but who pays WikiGen, and how much, is never said.
Competition3Only negative framing: "not another centralized data lake." No competitor named, no alternative (federated learning, synthetic data, brokers) displaced.
Traction1None. No pilot, biobank, sponsor, or user. The Q&A cites data-pricing research, which is homework, not traction.
Team4"I stem from a biotech background" is the right credential and it's stated early — but it stays one clause. No lab, no role, no result. Solo on stage.
The ask1"Help us make verifiable rewards a real reality" is a slogan. No amount, no milestone, nothing the room can do.

02 Klaff 5-lens audit · 1.5/5

Croc brainPARTIALThe Wiki name story is warm and memorable — then "Controls for scientists are like evals for your own evals" is near-incomprehensible and the croc brain checks out for two minutes.
FrameFAIL"I'm simply trying to help everyone" opens supplicant; "So I built WikiGen. I'm building it. [laughs]" retracts the pitch's strongest verb mid-sentence.
STRONG arcPARTIALParadox → question → mechanism → feature dump → vision. The turn to "What if data never had to be shared?" is a real beat; there is no proof beat and no ask beat.
Hot cognitionPARTIAL"It belongs to someone's life" lands — but the hottest line (a person with "no test… no cure") was given away in Q&A instead of the pitch.
StatusFAIL"I'm simply trying," the "I'm building it [laughs]" self-correction, "Perhaps a score…" — the pitch hedges its own existence.

THE ONE REORDER — Open on the paradox, put the Q&A line about the person with no test and no cure right after it, and end on a numbered ask instead of "Help us make verifiable rewards a real reality."

03 Delivery

Length
5:56
Pace
140 wpm
Fillers / 100 words
1.3

11 fillers ("um" ×4, "like" ×4) — genuinely low. The delivery problem is syntax, not filler: false starts like "home genome-- whole genome" and "I'm building it" do the damage fillers usually do.

04 Beat-by-beat

TimeBeatWhat worksThe fix
0:00Name open"No one speaks that alphabet… so I go by Wiki" — warm, human; the company name gets a faceOne sentence, then straight to the paradox — the next 45 seconds spend the goodwill
0:20Biotech evals tangleThe instinct to establish scientific credibility is right"Evals for your own evals… a laser is damp" is not parseable live. One concrete lab sentence: what you measured, what went wrong, what it cost
1:15The paradox"The most valuable biological data in the world is also the data least likely to move" — the best line in the pitchOpen with it
1:50Not a bug"The data is private for a good reason… It belongs to someone's life" — the emotional core of a custody productKeep verbatim
2:30MechanismFunded capped evaluation → custody kept → TEE → "only the output that was agreed in advance" — completeThree short sentences instead of one nested one; cut "the verifier can be swappable" — it un-sells the core
3:20Feature dump"Attested diligence rooms… governed data vaults… policy safeguards" — evidence a lot existsSeven features in one breath means the room retains zero. Pick one — the signed evaluation receipt — and walk it through
4:15Arena-session line—"The view is filtered only by the address recovered from your signed arena session" is documentation, not pitch. Cut, or show the screen it describes
4:40Close—"Help us make verifiable rewards a real reality" → replace with the ask: amount, first paid evaluation, first data owner
4:55Q&A: data value"As valuable as someone is affected by a condition that there is no test… or no cure" — the hottest cognition of the nightPromote into the pitch; source or drop the 0.03–0.10-cent EHR figure [confirm source]

05 The gaps investors block on

  1. No ask — "Help us make verifiable rewards a real reality" gives the room nothing to act on.
  2. Zero traction — no biobank, hospital, sponsor, or pilot named; a two-sided marketplace pitch with neither side present is a thesis, not a company.
  3. The chicken-and-egg is unaddressed — which side comes first? Every marketplace investor will ask.
  4. No business model — "funds a capped evaluation" gestures at a take rate that is never stated.
  5. No moat, and "the verifier can be swappable" actively argues against one.
  6. The only number in the session — the 0.03–0.10-cent EHR figure from Q&A — is unsourced and confusing as spoken. [confirm source]
The one strategic decision

Go demand-first: one sponsor, one question type. The pitch names five sponsor types and four data-owner types and commits to none. Land one biopharma or AI-science sponsor with a single funded, capped evaluation — a funded question is the only thing that gives a data owner a concrete reason to approve a use. The pitch's own mechanism starts with the sponsor; the company should too.

“WikiGen lets a biopharma company test its model against patient data a hospital will never share — the data never leaves the hospital's custody, the computation runs in an attested enclave, and the only thing that comes out is the score both sides agreed to in advance.”

06 The rewritten pitch

The most valuable biological data in the world is also the data least likely to move. Patient records, biobanks, proprietary sequences — private for good reason: it's regulated, it's sensitive, it belongs to someone's life. But somewhere there's a person with a condition that has no test and no cure, and the data that could change that is sitting in a vault nobody is allowed to open. When data can't move, science can't either.

I go by Wiki — I spent [N years / role] in biotech [confirm: lab/company], where I ran into that wall myself. So I'm building WikiGen: bring the model to the data, never the data to the model. A sponsor — a biopharma company, an AI scientist — defines a question and funds a capped evaluation. The hospital or biobank keeps full custody and approves that one use. The computation runs inside an attested confidential environment, and the only thing that ever leaves is the output both sides agreed to in advance: a score, a match, a signed evaluation receipt. Nobody ever sees the raw data. Not the sponsor. Not us.

This isn't another centralized data lake — it's the layer that lets institutions do science on data they will never share.

We're starting demand-first: [sponsor name / type] is [confirm: status] our first funded evaluation against [data owner]'s data. We're raising [$X] to run the first [N] paid evaluations and sign the first [M] governed vaults. If you know a biobank, a hospital data office, or a pharma eval team — that intro is the ask. Thank you.

Brackets are the founder's homework — the copy is done, the proof is theirs to supply. Every claim must match what's actually built.

07 Do these before the next take

  1. Pick the wedge: demand-first, one sponsor type, one question type. Everything else reorganizes around this.
  2. Write the ask — amount, number of paid evaluations it funds, first-vault milestone, and the intro you want from this room.
  3. Get one real name on each side of the marketplace — until then, every marketplace claim is bracketed.
  4. Promote the Q&A answer ("no test and no cure") into the pitch; it is the emotional engine and it was spent off-stage.
  5. Cut the arena-session line and the seven-item feature list; replace with a 60-second signed-receipt walkthrough.
  6. Source or drop the EHR pricing figure — the pitch's only number and its least defensible sentence.
  7. Rehearse for syntax, not filler — filler is already excellent (1.3/100); the false starts are the tell of unmemorized transitions.